Quick Answer
Ocean Biomedical, Inc. reported Stockholders Equity of -$97.62 million for the year ending 2024.
- Ocean Biomedical, Inc. showed a decrease of -1.4% in Stockholders Equity from 2024 to 2024.
- This data is from Ocean Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on April 8, 2025.
- XBRL data for this metric is available from 2021 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $24.9 thousand | Q3 2021: -$1.32 million | Q1 2022: -$7.49 million | Q2 2022: -$9.54 million | Q3 2022: -$9.84 million | Q1 2023: -$54.75 million | Q2 2023: -$61.66 million | Q3 2023: -$75.22 million | Q4 2023: -$90.76 million | Q1 2024: -$75.78 million | Q2 2024: -$92.74 million | Q4 2024: -$97.62 million | Q1 2025: -$92.40 million.
- Over the full 5 years of available data (2021 to 2024), Ocean Biomedical, Inc.'s Stockholders Equity has declined by 1,365.0%.
- Historical annual values: Fiscal year 2024: -$97.62 million | Fiscal year 2024: -$96.26 million | Fiscal year 2023: -$90.76 million | Fiscal year 2022: -$10.82 million | Fiscal year 2021: -$6.66 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: